SfE Obesity Management Symposium for the Endocrinologist - last chance to register!

Obesity drug fears investigated (BBC news online, 25 August 2009)

Breast cancer 'wonder drug' increases risk of rare tumour by 440% (Daily Mail, 26 August 2009)

26 Aug 2009

A side effect of Tamoxifen, used effectively to treat oestrogen-sensitive breast tumours has been revealed. A study shows the drug increases the risk of a rarer oestrogen-insensitive tumour developing in the opposite breast.

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read